|
WDR48 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.44090000048425E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.28430000000146E-05 |
| Normal-vs-Stage2 |
1.017350E-03 |
| Normal-vs-Stage3 |
2.53730000010499E-07 |
| Normal-vs-Stage4 |
2.76820000033595E-07 |
| Stage1-vs-Stage2 |
7.759400E-01 |
| Stage1-vs-Stage3 |
5.208300E-02 |
| Stage1-vs-Stage4 |
3.345900E-02 |
| Stage2-vs-Stage3 |
2.895000E-01 |
| Stage2-vs-Stage4 |
1.352770E-01 |
| Stage3-vs-Stage4 |
5.368800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73640000045161E-07 |
| Normal-vs-AfricanAmerican |
2.140400E-03 |
| Normal-vs-Asian |
6.920100E-03 |
| Caucasian-vs-AfricanAmerican |
8.906400E-01 |
| Caucasian-vs-Asian |
2.126400E-01 |
| AfricanAmerican-vs-Asian |
4.844800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.14660000000355E-06 |
| Normal-vs-Female |
9.54759999949317E-07 |
| Male-vs-Female |
8.339600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.228500E-04 |
| Normal-vs-Age(41-60Yrs) |
1.94310000001252E-06 |
| Normal-vs-Age(61-80Yrs) |
4.75820000067628E-08 |
| Normal-vs-Age(81-100Yrs) |
3.797700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.058200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.105900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.050400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.426400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.640800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.841600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.836300E-02 |
| Classical-VS-Follicular |
4.835400E-01 |
| Classical-VS-Other |
3.313600E-01 |
| Classical-VS-Normal |
2.06499999999554E-05 |
| Tall-VS-Follicular |
1.080820E-01 |
| Tall-VS-Other |
9.236600E-01 |
| Tall-VS-Normal |
4.20199999995319E-06 |
| Follicular-VS-Other |
5.113400E-01 |
| Follicular-VS-Normal |
1.398690E-04 |
| Other-VS-Normal |
1.484120E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79999999999825E-05 |
| Normal-vs-N1 |
2.14470000003963E-06 |
| N0-vs-N1 |
1.206840E-01 |
|
|
